VirtualScopics, LLC Receives Notice Of Allowance Of An Important Patent For Its DCE-MRI Product Portfolio

ROCHESTER, N.Y., Sept. 18 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. (Nasdaq: VSCP - News), a leading developer of image-based biomarker solutions, announced today that it has been issued U.S. Patent No. 7,103,224, "System and Method for Identifying Optimized Blood Signal in Medical Images to Eliminate Flow Artifacts" by the U.S. Patent and Trademark Office.
MORE ON THIS TOPIC